Suzuki H, DeLano F A, Parks D A, Jamshidi N, Granger D N, Ishii H, Suematsu M, Zweifach B W, Schmid-Schönbein G W
Department of Bioengineering and Institute for Biomedical Engineering, University of California at San Diego, La Jolla, CA 92093-0412, USA.
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4754-9. doi: 10.1073/pnas.95.8.4754.
Recent evidence in vivo indicates that spontaneously hypertensive rats (SHR) exhibit an increase in oxyradical production in and around microvascular endothelium. This study is aimed to examine whether xanthine oxidase plays a role in overproduction of oxidants and thereby may contribute to hypertensive states as a consequence of the increasing microvascular tone. The xanthine oxidase activity in SHR was inhibited by dietary supplement of tungsten (0.7 g/kg) that depletes molybdenum as a cofactor for the enzyme activity as well as by administration of (-)BOF4272 [(-)-8-(3-methoxy-4-phenylsulfinylphenyl)pyrazolo(1,5-alpha)-1,3, 5-triazine-4-monohydrate], a synthetic inhibitor of the enzyme. The characteristic elevation of mean arterial pressure in SHR was normalized by the tungsten diet, whereas Wistar Koto (WKY) rats displayed no significant alteration in the pressure. Multifunctional intravital videomicroscopy in mesentery microvessels with hydroethidine, an oxidant-sensitive fluoroprobe, showed that SHR endothelium exhibited overproduction of oxyradicals that coincided with the elevated arteriolar tone as compared with WKY rats. The tungsten diet significantly repressed these changes toward the levels observed in WKY rats. The activity of oxyradical-producing form of xanthine oxidase in the mesenteric tissue of SHR was approximately 3-fold greater than that of WKY rats, and pretreatment with the tungsten diet eliminated detectable levels of the enzyme activity. The inhibitory effects of the tungsten diet on the increasing blood pressure and arteriolar tone in SHR were also reproducible by administration of (-)BOF4272. These results suggest that xanthine oxidase accounts for a putative source of oxyradical generation that is associated with an increasing arteriolar tone in this form of hypertension.
近期的体内研究证据表明,自发性高血压大鼠(SHR)的微血管内皮及其周围的氧自由基生成增加。本研究旨在探讨黄嘌呤氧化酶是否在氧化剂的过量产生中起作用,从而可能由于微血管张力增加而导致高血压状态。通过膳食补充钨(0.7 g/kg)抑制SHR中的黄嘌呤氧化酶活性,钨会消耗作为该酶活性辅因子的钼,同时通过给予(-)BOF4272 [(-)-8-(3-甲氧基-4-苯基亚磺酰基苯基)吡唑并(1,5-α)-1,3,5-三嗪-4-一水合物],一种该酶的合成抑制剂。钨饮食使SHR中平均动脉压的特征性升高恢复正常,而Wistar Koto(WKY)大鼠的血压无明显变化。使用氧化还原敏感荧光探针氢乙锭对肠系膜微血管进行多功能活体视频显微镜检查显示,与WKY大鼠相比,SHR内皮表现出氧自由基的过量产生,这与小动脉张力升高一致。钨饮食显著抑制了这些变化,使其接近WKY大鼠中观察到的水平。SHR肠系膜组织中产生氧自由基形式的黄嘌呤氧化酶活性比WKY大鼠高约3倍,钨饮食预处理消除了可检测到的酶活性水平。给予(-)BOF4272也可重现钨饮食对SHR血压升高和小动脉张力增加的抑制作用。这些结果表明,黄嘌呤氧化酶是氧自由基产生的一个假定来源,与这种形式的高血压中不断增加的小动脉张力有关。